Healthcare News and Research

Latest Healthcare News and Research

Bio-Reference Laboratories reports third-quarter fiscal 2009 revenues

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $97,424, the best ever quarter in terms of revenues in corporate history and an increase of more than 25% over the $77,776 recorded in the third quarter, fiscal year 2008.

3 Sep 2009

Rural states with much to gain under reform also feature most vocal opponents

The Los Angeles Times reports: "Some of the most vociferous opposition to the proposals before the House and Senate comes from residents of rural states that could benefit most if the present system is revamped.

3 Sep 2009

New clinical trials to address the effectiveness of antimicrobial drugs

Scientists are addressing the threat of antimicrobial drug resistance by launching two new clinical trials aimed at prolonging the effectiveness of currently available antibacterial drugs. The concept underlying both studies: Less is more.

3 Sep 2009

Implanet to use IBM's sensor technology for its new implant device tracking service

Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

3 Sep 2009

Riverside Medical Center adds two more doctors

Internal Medicine Physician Rahul Deepankar, M.D. and Pediatrician Jane Kapral, M.D. are the two newest team members to join the Riverside Medical Center - West Campus in Coal City.

3 Sep 2009

Algeta partners with Bayer for development and commercialization of Alpharadin drug

Algeta Retains Option for Co-promotion and Profit Sharing in USA - Potential deal value of $800 million (EUR560m*) plus tiered double digit royalties - Algeta to receive $61 million (EUR42.5m) cash upfront, followed by development and sales milestones - Algeta retains option for co-promotion and profit-sharing in USA - Algeta and Bayer will jointly develop Alpharadin, with Bayer contributing a substantial majority of the costs of future development

3 Sep 2009

New device for treating hypoglycemia launched globally

At this year’s annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia.

3 Sep 2009

Pioneer in the eHealth industry calls for calm in healthcare debate

In the midst of a tempestuous healthcare debate, one private citizen is proving you don't have to shout to be heard. A pioneer in the eHealth industry, Steve Parker, Jr., speaks with the calm voice of reason. His online call for a careful, strategic approach to reform is attracting the attention of business leaders inside and outside the healthcare industry, as well as everyday Americans currently struggling to pay their medical bills.

3 Sep 2009

SPi acquires Laguna Medical Systems for $8.25 million

SPi, a leading global business process outsourcing (BPO) company, today announced that it has acquired Laguna Medical Systems, Inc. (LMS) for an aggregate purchase price of US $8.25 million.

3 Sep 2009

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

3 Sep 2009

Pfizer to pay $2.3 billion for health care fraud settlement

American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together "Pfizer") have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department announced today.

3 Sep 2009

Senate Republicans prepare robust objections to stall Democrat's health reform bill

Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.

3 Sep 2009

Researchers to analyse nanoparticles

Researchers at Swansea University's Centre for NanoHealth have been awarded £1 million by the Research Councils' Nanoscience through Engineering to Application cross-council programme, led by the Engineering and Physical Science Research Council (EPSRC), to analyse the levels at which nanoparticles can be deemed safe within cells.

3 Sep 2009

Research reveals that 21% of death claims are rejected by California's largest private insurers

More than one of every five requests for medical claims for insured patients, even when recommended by a patient's physician, are rejected by California's largest private insurers, amounting to very real death panels in practice daily in the nation's biggest state, according to data released today by the California Nurses Association/National Nurses Organizing Committee.

3 Sep 2009

Intendis GmbH forges agreement with SkinMedica to acquire two prescription dermatology products

Asset Purchase Agreement Signed for Marketed Prescription Products Desonate(R) and NeoBenz(R) Micro

3 Sep 2009

Hong Kong's healthcare workers to refuse H1N1 vaccine, says study

According to a study released August 26, 2009 by the British Medical Journal, more than half of Hong Kong's healthcare workers surveyed said they would refuse the H1N1 shot, which is not yet available, because they are afraid of side effects and doubt how safe and effective it will be. More importantly, the study suggested the trend would be repeated worldwide.

3 Sep 2009

New therapy for advanced and metastatic basal cell skin cancer

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

3 Sep 2009

AVA issues guidelines for disinfecting IV catheters

How to meet new infection-control guidelines from the Joint Commission and the SHEA/IDSA Compendium will be the focus of a panel discussion at the upcoming annual meeting of the Association for Vascular Access (AVA).

3 Sep 2009

An already-changing insurance market may face more transformation

The Wall Street Journal: "Insurers are increasingly setting up brick-and-mortar retail stores that peddle individual and sometimes small-group health plans, with companies including Humana Inc., Aetna Inc. and Health Net Inc. so far trying the concept. Blue Cross Blue Shield plans in Pennsylvania and South Carolina say they've had good results from shops, while Blue Cross & Blue Shield of Florida Inc. plans to add five more locations after the success of its existing two."

2 Sep 2009

Rxeob appoints Sales Director to advance Strategic Health Plan Solution campaign

RxEOB, the industry leader in providing personalized online member communication features and advanced pharmacy benefit data solutions, is pleased to welcome Shaw Newman as Sales Director for RxEOB's Strategic Health Plan Solution campaign.

2 Sep 2009